Harvard Health Blog
Active surveillance is safe for low-risk prostate cancers
Posted November 06, 2015, 8:00 am Charlie Schmidt, Editor, Harvard Medical School Annual Report on Prostate Disease Active surveillance is becoming a widely adopted alternative for some men with prostate cancer. Instead of having immediate treatment, men on active surveillance are monitored with periodic biopsies, physical exams of the prostate, and prostate-specific antigen (PSA) tests. Treatment begins only when the cancer shows signs of progression.